Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of 10 mg of oral zinc given daily
between days 2 and 7 of life to term or near term neonates with serum bilirubin levels of
more than 6 mg/dL at 24 ± 6 hours of life on hyperbilirubinemia and phototherapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
All India Institute of Medical Sciences, New Delhi